DOI: 10.7504/nk2015120504
Comparison of efficacy and safety between rituximab plus CHOP and etoposide plus CHOP regimen in the treatment of patients with diffuse large B-cell lymphoma
LIN Dong-jing
FU Di
PENG Mei
WANG Rui
LI Shu-cheng
LIAO Ai-jun
Keywords:diffuse large B-cell lymphomarituximabetoposide
Publication Date:2016-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
